These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 27649851)
1. Clinical characteristics of eosinophilic asthma exacerbations. Bjerregaard A; Laing IA; Backer V; Fally M; Khoo SK; Chidlow G; Sikazwe C; Smith DW; Le Souëf P; Porsbjerg C Respirology; 2017 Feb; 22(2):295-300. PubMed ID: 27649851 [TBL] [Abstract][Full Text] [Related]
2. Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults. Bjerregaard A; Laing IA; Poulsen N; Backer V; Sverrild A; Fally M; Khoo SK; Barrett L; Baltic S; Thompson PJ; Chidlow G; Sikazwe C; Smith DW; Bochkov YA; Le Souëf P; Porsbjerg C Respir Med; 2017 Feb; 123():34-41. PubMed ID: 28137494 [TBL] [Abstract][Full Text] [Related]
3. Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis. Petsky HL; Cates CJ; Kew KM; Chang AB Thorax; 2018 Dec; 73(12):1110-1119. PubMed ID: 29858277 [TBL] [Abstract][Full Text] [Related]
4. Effects of treatment changes on asthma phenotype prevalence and airway neutrophil function. Brooks CR; Van Dalen CJ; Harding E; Hermans IF; Douwes J BMC Pulm Med; 2017 Dec; 17(1):169. PubMed ID: 29202821 [TBL] [Abstract][Full Text] [Related]
5. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study. McDowell PJ; Diver S; Yang F; Borg C; Busby J; Brown V; Shrimanker R; Cox C; Brightling CE; Chaudhuri R; Pavord ID; Heaney LG; Lancet Respir Med; 2021 Oct; 9(10):1174-1184. PubMed ID: 33971168 [TBL] [Abstract][Full Text] [Related]
6. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD. Gao J; Zhang M; Zhou L; Yang X; Wu H; Zhang J; Wu F Int J Chron Obstruct Pulmon Dis; 2017; 12():1287-1293. PubMed ID: 28490872 [TBL] [Abstract][Full Text] [Related]
7. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Wagener AH; de Nijs SB; Lutter R; Sousa AR; Weersink EJ; Bel EH; Sterk PJ Thorax; 2015 Feb; 70(2):115-20. PubMed ID: 25422384 [TBL] [Abstract][Full Text] [Related]
8. Clinical and inflammatory features of asthma with dissociation between fractional exhaled nitric oxide and eosinophils in induced sputum. Crespo A; Giner J; Torrejón M; Belda A; Mateus E; Granel C; Torrego A; Ramos-Barbón D; Plaza V J Asthma; 2016 Jun; 53(5):459-64. PubMed ID: 26785727 [TBL] [Abstract][Full Text] [Related]
9. Can we predict sputum eosinophilia from clinical assessment in patients referred to an adult asthma clinic? Yap E; Chua WM; Jayaram L; Zeng I; Vandal AC; Garrett J Intern Med J; 2013 Jan; 43(1):46-52. PubMed ID: 21790924 [TBL] [Abstract][Full Text] [Related]
10. Exacerbations of asthma without sputum eosinophilia. Turner MO; Hussack P; Sears MR; Dolovich J; Hargreave FE Thorax; 1995 Oct; 50(10):1057-61. PubMed ID: 7491553 [TBL] [Abstract][Full Text] [Related]
11. Asthma Phenotypes Defined From Parameters Obtained During Recovery From a Hospital-Treated Exacerbation. Qiu R; Xie J; Chung KF; Li N; Yang Z; He M; Li J; Chen R; Zhong N; Zhang Q J Allergy Clin Immunol Pract; 2018; 6(6):1960-1967. PubMed ID: 29477568 [TBL] [Abstract][Full Text] [Related]
12. Correlation of eosinophil counts in induced sputum and fractional concentration of exhaled nitric oxide and lung functions in patients with mild to moderate asthma. Wang W; Huang KW; Wu BM; Wang YJ; Wang C Chin Med J (Engl); 2012 Sep; 125(17):3157-60. PubMed ID: 22932198 [TBL] [Abstract][Full Text] [Related]
13. Cutoff point for exhaled nitric oxide corresponding to 3% sputum eosinophils. Alvarez-Puebla MJ; Olaguibel Rivera JM; Almudevar E; Echegoyen AA; de Esteban Chocarro B; Cambra K J Investig Allergol Clin Immunol; 2015; 25(2):107-11. PubMed ID: 25997303 [TBL] [Abstract][Full Text] [Related]
14. Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide. Soter S; Barta I; Antus B Inflammation; 2013 Oct; 36(5):1178-85. PubMed ID: 23681903 [TBL] [Abstract][Full Text] [Related]
15. Mannitol versus hypertonic saline: Safety and efficacy of mannitol and hypertonic saline in sputum induction and bronchial hyperreactivity assessment. Alvarez-Puebla MJ; Olaguibel JM; Almudevar E; Echegoyen AA; Vela C; de Esteban B Chron Respir Dis; 2015 Aug; 12(3):197-203. PubMed ID: 25761367 [TBL] [Abstract][Full Text] [Related]
16. Validity of Fractional Exhaled Nitric Oxide in Diagnosis of Corticosteroid-Responsive Cough. Yi F; Chen R; Luo W; Xu D; Han L; Liu B; Jiang S; Chen Q; Lai K Chest; 2016 Apr; 149(4):1042-51. PubMed ID: 26836931 [TBL] [Abstract][Full Text] [Related]
17. Exhaled nitric oxide thresholds associated with a sputum eosinophil count ≥3% in a cohort of unselected patients with asthma. Schleich FN; Seidel L; Sele J; Manise M; Quaedvlieg V; Michils A; Louis R Thorax; 2010 Dec; 65(12):1039-44. PubMed ID: 20671307 [TBL] [Abstract][Full Text] [Related]
18. Relationship of Blood Eosinophils with Fractional Exhaled Nitric Oxide and Pulmonary Function Parameters in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation. Tang B; Huang D; Wang J; Luo LL; Li QG Med Sci Monit; 2020 Mar; 26():e921182. PubMed ID: 32161254 [TBL] [Abstract][Full Text] [Related]
19. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Petsky HL; Cates CJ; Lasserson TJ; Li AM; Turner C; Kynaston JA; Chang AB Thorax; 2012 Mar; 67(3):199-208. PubMed ID: 20937641 [TBL] [Abstract][Full Text] [Related]
20. Changes in sputum eosinophils predict loss of asthma control. Jatakanon A; Lim S; Barnes PJ Am J Respir Crit Care Med; 2000 Jan; 161(1):64-72. PubMed ID: 10619799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]